Literature DB >> 18418037

Butyrate and Wnt signaling: a possible solution to the puzzle of dietary fiber and colon cancer risk?

Michael Bordonaro1, Darina L Lazarova, Alan C Sartorelli.   

Abstract

Studies on the protective role of dietary fiber and its breakdown product butyrate against colorectal cancer (CRC) have yielded inconsistent findings. We have reported that butyrate treatment of CRC cells in vitro modulates canonical Wnt signaling, a pathway which is constitutively activated in the majority of CRCs. Analyses of ten human CRC cell lines exposed to butyrate have established that the levels of apoptosis in these cells are dependent upon the fold induction of canonical Wnt transcriptional activity. It is likely that the observed variability in the levels of induced Wnt activity and apoptosis in CRC cells in vitro reflects the existence of different CRC subtypes in vivo. The existence of CRC subtypes, individual- and population-specific variation in butyrate producing colonic microflora, and the time at which the colorectal lesions (early vs. late stage) are exposed to fiber/butyrate are all factors that may influence the protective role of fiber against CRC. We discuss the evidence by which these factors influence the effects of fiber on colonic tumorigenesis and outline experimental approaches for testing these hypotheses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418037     DOI: 10.4161/cc.7.9.5818

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  47 in total

Review 1.  A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects.

Authors:  Harold Tjalsma; Annemarie Boleij; Julian R Marchesi; Bas E Dutilh
Journal:  Nat Rev Microbiol       Date:  2012-06-25       Impact factor: 60.633

Review 2.  Nutrient-Gene Interaction in Colon Cancer, from the Membrane to Cellular Physiology.

Authors:  Tim Y Hou; Laurie A Davidson; Eunjoo Kim; Yang-Yi Fan; Natividad R Fuentes; Karen Triff; Robert S Chapkin
Journal:  Annu Rev Nutr       Date:  2016-07-17       Impact factor: 11.848

Review 3.  Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.

Authors:  Roberto Berni Canani; Margherita Di Costanzo; Ludovica Leone; Monica Pedata; Rosaria Meli; Antonio Calignano
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

Review 4.  Reevaluating the hype: four bacterial metabolites under scrutiny.

Authors:  E E Fröhlich; R Mayerhofer; P Holzer
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

Review 5.  Mechanisms linking dietary fiber, gut microbiota and colon cancer prevention.

Authors:  Huawei Zeng; Darina L Lazarova; Michael Bordonaro
Journal:  World J Gastrointest Oncol       Date:  2014-02-15

6.  Mechanisms by Which Pleiotropic Amphiphilic n-3 PUFA Reduce Colon Cancer Risk.

Authors:  Robert S Chapkin; Vanessa DeClercq; Eunjoo Kim; Natividad Roberto Fuentes; Yang-Yi Fan
Journal:  Curr Colorectal Cancer Rep       Date:  2014-12-01

7.  Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans.

Authors:  Junhai Ou; Franck Carbonero; Erwin G Zoetendal; James P DeLany; Mei Wang; Keith Newton; H Rex Gaskins; Stephen J D O'Keefe
Journal:  Am J Clin Nutr       Date:  2013-05-29       Impact factor: 7.045

8.  HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling.

Authors:  Cassandra A Godman; Rashmi Joshi; Brendan R Tierney; Emily Greenspan; Theodore P Rasmussen; Hsin-Wei Wang; Dong-Guk Shin; Daniel W Rosenberg; Charles Giardina
Journal:  Cancer Biol Ther       Date:  2008-10-07       Impact factor: 4.742

9.  Fecal microbes, short chain fatty acids, and colorectal cancer across racial/ethnic groups.

Authors:  Christina M Hester; Venkatakrishna R Jala; Morgan Gi Langille; Shahid Umar; K Allen Greiner; Bodduluri Haribabu
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

Review 10.  Modular Cre/lox system and genetic therapeutics for colorectal cancer.

Authors:  Michael Bordonaro
Journal:  J Biomed Biotechnol       Date:  2009-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.